RT Book, Section
A1 Mathur, Aditi
A1 Antin-Ozerkis, Danielle E.
A2 Grippi, Michael A.
A2 Antin-Ozerkis, Danielle E.
A2 Dela Cruz, Charles S.
A2 Kotloff, Robert M.
A2 Kotton, Camille Nelson
A2 Pack, Allan I.
SR Print(0)
ID 1195005403
T1 Interstitial Lung Disease: A Clinical Overview and General Approach
T2 Fishman’s Pulmonary Diseases and Disorders, 6e
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781260473988
LK accessmedicine.mhmedical.com/content.aspx?aid=1195005403
RD 2024/04/24
AB Interstitial  lung  disease  (ILD)  refers  to  a  heterogenous  collection  of  lung  disorders  that  are  grouped  together  because  they  share  clinical,  radiographic,  and  pathologic  features.  ILD  is  also  referred  to  as  diffuse  parenchymal  lung  disease  (DPLD)  to  clarify  that  the  interstitium  is  not  the  only  compartment  of  the  lung  affected.  For  example,  organizing  pneumonia  and  pulmonary  alveolar  proteinosis  are  alveolar  filling  processes,  whereas  respiratory  bronchiolitis  and  chronic  hypersensitivity  pneumonitis  may  center  on  the  airway.  Occasionally,  purely  airway-centered  disease  like  bronchiolitis  obliterans  may  be  initially  identified  as  an  ILD  because  of  overlapping  radiographic  features.  A  structured  approach  is  necessary  since  prognosis  and  therapy  vary  considerably  depending  on  the  diagnosis.  While  many  ILDs  are  extremely  rare,  there  are  some,  such  as  idiopathic  pulmonary  fibrosis  (IPF)  and  sarcoidosis,  that  are  seen  commonly  in  general  pulmonary  practice.